The emergence of HER2-low therapies for metastatic breast cancer is a paradigm shift in the traditional binary classification of a patient’s HER2 status, creating a need for practice changes in pathology necessitated by the expansion in how HER2-low breast cancer needs to be classified and treated. During this recorded 2022 ASCP Annual Meeting session, a moderated expert faculty panel will discuss evolving and emerging trends in breast cancer classification and reporting across the HER2+ spectrum. They will also discuss how pathologists and laboratory professionals can prepare for HER2-low classification, tracking, and reporting. In addition, they will review some of the current challenges in HER2 testing and explore opportunities to prepare for the future landscape of HER classification in breast cancer. The activity offers 1.0 CME/CMLE credit. The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Faculty
Swikrity U. Baskota, MD
Assistant Professor, Department of Pathology, and Cell Biology
Columbia University Irving Medical Center
Marilyn Bui, MD, PhD
Senior Member and Professor of Pathology
Scientific Director of Analytic Microscopy Core
Program Director of Cytopathology Fellowship
Moffitt Cancer Center & Research Institute
Mamatha Chivukula, MD, FASCP
Director of Breast Pathology Services and IHC Lab
Mills Peninsula Medical Center, Sutter Health Affiliate
Joseph Kim, MD, MBA, MPH
President
Q Synthesis
Credit Designation Statement The ASCP designates this enduring podcast activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. ASCP designates this enduring podcast activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation To complete the activity and receive credit, the participant must complete the podcast activity. CME certificates will be provided on-line.
Commercial Support
Funded by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.
Provided by the American Society for Clinical Pathology in partnership with Q Synthesis.
Women Trailblazers in a Multigenerational Workplace
Special Episode: Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
Special Episode: CRC Biomarkers and the Impact on Patients’ Lives
Special Episode: Emerging Biomarkers for the Assessment of Alzheimer's Disease
Special Episode:How Advances in Treatment for NSCLC and Melanoma Impact the Laboratory
S4Ep2: The FDA’s Proposed Rule on Laboratory Developed Tests
S4Ep1: Patient-Centered Care from a Laboratory Perspective
S3Ep15: Strategies for Promoting DEI in the Lab
S3Ep14: Mentorship in the Medical Laboratory
S3Ep13: A Storied Career in Gynecologic Pathology—featuring Dr. Elvio Silva
S3Ep12: Transitioning to Leadership Outside the Laboratory
S3Ep11: 10 Lab Safety Issues That Put You at Risk
S3EP10: Saved by the Lab: A LIVE ‘90s Trivia Contest
S3Ep9-Sometimes It’s a Zebra: Unusual Cases in the Microbiology Lab
S3Ep8: Amplifying the Voice of Pathology in the AMA
S3Ep7: Everything You Need to Know About RISE
Special Episode: Castleman's Disease
S3Ep6:Leadership Institute Book Club: Invisible Women by Caroline Criado Perez
S3Ep5: Sometimes It’s a Zebra: Unusual Cases in Surgical Pathology—with Dr. Cesar Moran
S3Ep4: Leading Laboratories
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.